University of Texas MD Anderson Cancer Center

Prognostic markers in pT3 bladder cancer: A study from the international bladder cancer tissue microarray project (2021) Wang G, Black PC, Goebell P, Ji L, Cordon-Cardo C, Schmitz-Dräger B, Hawes D, et al. Journal article A cross-disease meta-GWAS identifies four new susceptibility loci shared between systemic sclerosis and Crohn’s disease (2020) González-Serna D, Ochoa E, López-Isac E, Julià A, Degenhardt F, Ortego-Centeno N, Radstake TR, et al. Journal article Multicenter International Society for Immunotherapy of Cancer Study of the Consensus Immunoscore for the Prediction of Survival and Response to Chemotherapy in Stage III Colon Cancer (2020) Mlecnik B, Bifulco C, Bindea G, Marliot F, Lugli A, Lee JJ, Zlobec I, et al. Journal article Elotuzumab, lenalidomide, and dexamethasone in RRMM: final overall survival results from the phase 3 randomized ELOQUENT-2 study (2020) Dimopoulos MA, Lonial S, White D, Moreau P, Weisel K, San-Miguel J, Shpilberg O, et al. Journal article EPIK-B3: A phase III, randomised, double-blind (DB), placebo (PBO)-controlled study of alpelisib (ALP) plus nab-paclitaxel (nabPTX) in advanced triple-negative breast cancer (TNBC) with either PIK3CA mutation or phosphatase and tensin homolog (PTEN) loss without PIK3CA mutation (2020) Sharma P, Farooki A, Fasching P, Loi S, Peterson K, Prat A, Tripathy D, et al. Conference contribution Ambulatory assessment for physical activity research: State of the science, best practices and future directions (2020) Reichert M, Giurgiu M, Koch ED, Wieland LM, Lautenbach S, Neubauer AB, von Haaren-Mack B, et al. Journal article, Review article The BiTE (bispecific T-cell engager) platform: Development and future potential of a targeted immuno-oncology therapy across tumor types (2020) Einsele H, Borghaei H, Orlowski RZ, Subklewe M, Roboz GJ, Zugmaier G, Kufer P, et al. Journal article, Review article Predictors of progression in systemic sclerosis patients with interstitial lung disease (2020) Distler O, Assassi S, Cottin V, Cutolo M, Danoff SK, Denton CP, Distler J, et al. Journal article, Review article Re: Aurélie Kamoun, Aurélien de Reyniès, Yves Allory, et al. A Consensus Molecular Classification of Muscle-invasive Bladder Cancer. Eur Urol 2020;77:420–33: A Statement from the International Bladder Cancer Network (2020) Williams SB, Black PC, Dyrskjøt L, Seiler R, Schmitz-Dräger B, Nawroth R, Todenhöfer T, et al. Journal article, Letter Cemiplimab in locally advanced cutaneous squamous cell carcinoma: results from an open-label, phase 2, single-arm trial (2020) Migden MR, Khushalani NI, Chang ALS, Lewis KD, Schmults CD, Hernandez-Aya L, Meier F, et al. Journal article